Overview A Study to Assess the Effect of Food on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants Status: Completed Trial end date: 2019-12-09 Target enrollment: Participant gender: Summary The primary objective of the study is to evaluate the PK of AMG 510 administered in the fasted and fed state in healthy participants. Phase: Phase 1 Details Lead Sponsor: Amgen